Sitagliptin / Metformin hydrochloride Mylan Europäische Union - Deutsch - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sitagliptin / Metformin hydrochloride Accord Europäische Union - Deutsch - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sitagliptin/Metformin Sandoz 50 mg - 850 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sitagliptin/metformin sandoz 50 mg - 850 mg filmtablette

sandoz - sitagliptin hydrochloride monohydrate; metformin hydrochlorid - filmtablette - 50 mg - 850 mg - sitagliptin hydrochloride monohydrate 56.685 mg; metformin hydrochlorid 850 mg - metformin and sitagliptin

Sitagliptin/Metformin Sandoz 50 mg - 1000 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sitagliptin/metformin sandoz 50 mg - 1000 mg filmtablette

sandoz - sitagliptin hydrochloride monohydrate; metformin hydrochlorid - filmtablette - 50 mg - 1000 mg - sitagliptin hydrochloride monohydrate 56.685 mg; metformin hydrochlorid 1000 mg - metformin and sitagliptin

Sitagliptin/Metformin Sandoz GmbH 50 mg - 850 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sitagliptin/metformin sandoz gmbh 50 mg - 850 mg filmtablette

sandoz - sitagliptin hydrochloride monohydrate; metformin hydrochlorid - filmtablette - 50 mg - 850 mg - sitagliptin hydrochloride monohydrate 56.7 mg; metformin hydrochlorid 850 mg - metformin and sitagliptin

Sitagliptin/Metformin Sandoz GmbH 50 mg - 1000 mg Filmtablette Belgien - Deutsch - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sitagliptin/metformin sandoz gmbh 50 mg - 1000 mg filmtablette

sandoz - sitagliptin hydrochloride monohydrate; metformin hydrochlorid - filmtablette - 50 mg - 1000 mg - sitagliptin hydrochloride monohydrate 56.7 mg; metformin hydrochlorid 1000 mg - metformin and sitagliptin